Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allucent
Cary, NC, USAallucent.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Allucent has supported over a thousand clinical trials across more than seventy countries with deep expertise in complex disease areas. The majority of its work centers on oncology and advanced therapeutic modalities for small to mid-sized biotech clients. It provides end-to-end services including regulatory consulting, trial design/execution from preclinical to post-marketing phases. No proprietary clinical results as it does not own drug assets.
- Therapeutic areas
- ImmunologyHematologyOncologyRare DiseasesNeurology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Bispecific antibodiesAntibody-drug conjugates (ADCs)Cell therapiesGene therapiesNanoparticle formulationsVaccines (anticancer vaccines)
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on Allucent.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allucent.